Table 1.

Details of patients’ characteristics (including disease and treatment).

#	Age (Years) at:			IDC 1	ILC 2	HER2	Site of Metastasis	Treatment
	Collection	Diagnosis	Death
1	66	43	67	√	√	+	Liver, lung, bone	Chemotherapy (carboplatin/gemzar)
2	57	56	58	√	×	−	Liver, bone	Hormonal and Palbocyclib
3	36	27	37	√	×	−	Bone, lung	Chemotherapy (cyclophosphamide/methotrexate/5FU 3)
4	55	54		√	×	+	Local disease	Chemotherapy (adriamycin/cyclophosphamide (neoadjuvant))
5	53	49	55	√	×	−	Bone, liver	Avastin
6	40	33	41	√	×	−	Bone, liver	Avastin and Chemotherapy (cisplatin/gemzar)
7	33	33		√	×	+	Local disease	Targeted therapy for HER2 and Chemotherapy (navalbine (neaoadjuvant))
8	64	54	66	√	×	−	Bone, liver	Chemotherapy (carboplatin/gemzar)
9	38	32	39	√	×	+	Bone, lung	Targeted therapy for HER2
10	37	36		√	×	+	Brain	Targeted therapy for HER2
11	62	46	64	√	×	−	Liver, bone	Chemotherapy (carboplatin/gemzar)
12	84	76		√	×	+	Local disease	Targeted therapy for HER2 and Chemotherapy (navalbine (neaoadjuvant))
13	54	36	56	√	×	−	Bone, lung, liver	Chemotherapy (cisplatin/leucovorin/5FU 3)
14	58	58		√	×	+		Targeted therapy for HER2
15	71	69	72	√	×	−	Lung, liver, bone	Hormonal
16	53	53		√	×	−		Chemotherapy (taxol (adjuvant))
17	55	49		√	×	−	Lung, bone	Avastin and Chemotherapy (navalbine)
18	85	80	85	√	×	−	Liver, bone, lung	Chemotherapy (carboplatin)
19	49	48		√	×	+		Targeted therapy for HER2
20	35	35		√	×	−	Local disease	Chemotherapy (taxol (neoadjuvant))
21	67	64	68	×	√	−	Brain, bone, lung	Chemotherapy (carboplatin + taxol)
22	47	42	47	√	×	−	Bone, liver	Chemotherapy (carboplatin/gemzar)
23	46	45		√	×	+		Targeted therapy for HER2
24	54	41	55	√	×	−	Bone	Hormonal and Palbocyclib
25	51	51	52	√	×	−	Bone	Hormonal and Palbocyclib
26	35	29	36	√	×	−	Liver, bone, adrenal gland	Hormonal and Afinitor
27	62	62		×	√	−		Chemotherapy (taxol (adjuvant))
28	39	39	40	√	×	−	Bone	Hormonal and Palbocyclib
29	58	52	59	√	×	−	Bone	Chemotherapy (taxol)
30	56	43	57	√	×	−	Liver, bone	Hormonal and Afinitor
31	52	52	53	√	×	−	Bone, liver	Chemotherapy (xeloda)

¹ IDC: Invasive/infiltrating ductal carcinoma; ² ILC: invasive/infiltrating lobular carcinoma; ³ 5FU: fluorouracil.